Silo Pharma (SILO) Retained Earnings (2010 - 2026)
Silo Pharma (SILO) posted Retained Earnings of $8721.0 for Q1 2026, up 49.64% sequentially from $5828.0 in Q4 2025, and down 18.53% YoY from $10704.0 in Q1 2025.
Silo Pharma (SILO) Retained Earnings (2010 - 2026) Analysis & Trends
Silo Pharma has reported Retained Earnings for 14 years, with the latest figure at $8721.0 in Q1 2026.
- Quarterly Retained Earnings fell 18.53% year-over-year to $8721.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8721.0 (down 18.53% YoY) and the FY2025 annual result came in at $5828.0, up 140.93% from the prior year.
- Retained Earnings grew to $8721.0 in Q1 2026 per SILO's latest filing, from $5828.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $23.6 million in Q3 2025 and troughed at -$17.5 million in Q2 2025.
- A 5-year average of $2.9 million and a median of $8721.0 in 2026 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 119146.9% in 2025, down 218146.61% in 2025.
- Over 5 years, Retained Earnings stood at -$7.2 million in 2022, then soared by 344.39% to $17.5 million in 2023, then tumbled by 99.99% to $2419.0 in 2024, then surged by 140.93% to $5828.0 in 2025, then surged by 49.64% to $8721.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $8721.0, $5828.0, and $23.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 4.38 Bn |
| 10 | Silo Pharma | 2.99 Mn | 2.99 Mn | - | 26.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.85 Mn |
| Mar 31, 2026 | 8,721.00 |
| Dec 31, 2025 | 5,828.00 |
| Sep 30, 2025 | 23.61 Mn |
| Jun 30, 2025 | -17.50 Mn |
| Mar 31, 2025 | 10,704.00 |
| Dec 31, 2024 | 2,419.00 |
| Sep 30, 2024 | 19,797.00 |
| Jun 30, 2024 | 8,026.00 |
| Mar 31, 2024 | -11.67 Mn |
| Dec 31, 2023 | 17.53 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Mar 31, 2023 | 17.52 Mn |
| Dec 31, 2022 | -7.17 Mn |
| Sep 30, 2022 | -5.51 Mn |
| Jun 30, 2022 | 12.39 Mn |
| Mar 31, 2022 | 12.41 Mn |
| Dec 31, 2021 | 12.32 Mn |
| Sep 30, 2021 | 12.31 Mn |